Harvard Bioscience, Inc. (HBIO) News

Harvard Bioscience, Inc. (HBIO): $4.30

0.07 (+1.65%)

POWR Rating

Component Grades








Filter HBIO News Items

HBIO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HBIO News Highlights

  • HBIO's 30 day story count now stands at 3.
  • Over the past 16 days, the trend for HBIO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • PRE are the most mentioned tickers in articles about HBIO.

Latest HBIO News From Around the Web

Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.

Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)?

While Harvard Bioscience, Inc. ( NASDAQ:HBIO ) might not be the most widely known stock at the moment, it received a...

Yahoo | September 26, 2023

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense’s non-invasive telemetry jacket and associated

Yahoo | September 18, 2023

Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 36% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Harvard Bioscience is US$6.54 based on 2 Stage Free Cash Flow to Equity...

Yahoo | September 10, 2023

Harvard Bioscience President Acquires 1.6% More Stock

Potential Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders may wish to note that the President, James Green...

Yahoo | August 24, 2023

Sidoti Events, LLC’s Virtual August Micro-Cap Conference

Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change.

Yahoo | August 15, 2023

Q2 2023 Harvard Bioscience Inc Earnings Call

Q2 2023 Harvard Bioscience Inc Earnings Call

Yahoo | August 9, 2023

Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates

Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 2.51%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 8, 2023

Harvard Bioscience Announces Second Quarter 2023 Financial Results

Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2023. Jim Green, Chairman and CEO said, “We are encouraged by the continuation of a strong start to the fiscal year, with growth from new produc

Yahoo | August 8, 2023

Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023

HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. The presentation will begin at 11:30 a.m. ET on Wednesday, August 16th and can be accessed live here. The presentation will also be archived on the Investor

Yahoo | August 3, 2023

Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET

HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who would like to join the audio-on

Yahoo | July 27, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!